© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Sang Won Shin, MD
Articles
Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma
September 02, 1997
Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided